» Articles » PMID: 38400021

Prior Influenza Infection Mitigates SARS-CoV-2 Disease in Syrian Hamsters

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2024 Feb 24
PMID 38400021
Authors
Affiliations
Soon will be listed here.
Abstract

Seasonal infection rates of individual viruses are influenced by synergistic or inhibitory interactions between coincident viruses. Endemic patterns of SARS-CoV-2 and influenza infection overlap seasonally in the Northern hemisphere and may be similarly influenced. We explored the immunopathologic basis of SARS-CoV-2 and influenza A (H1N1pdm09) interactions in Syrian hamsters. H1N1 given 48 h prior to SARS-CoV-2 profoundly mitigated weight loss and lung pathology compared to SARS-CoV-2 infection alone. This was accompanied by the normalization of granulocyte dynamics and accelerated antigen-presenting populations in bronchoalveolar lavage and blood. Using nasal transcriptomics, we identified a rapid upregulation of innate and antiviral pathways induced by H1N1 by the time of SARS-CoV-2 inoculation in 48 h dual-infected animals. The animals that were infected with both viruses also showed a notable and temporary downregulation of mitochondrial and viral replication pathways. Quantitative RT-PCR confirmed a decrease in the SARS-CoV-2 viral load and lower cytokine levels in the lungs of animals infected with both viruses throughout the course of the disease. Our data confirm that H1N1 infection induces rapid and transient gene expression that is associated with the mitigation of SARS-CoV-2 pulmonary disease. These protective responses are likely to begin in the upper respiratory tract shortly after infection. On a population level, interaction between these two viruses may influence their relative seasonal infection rates.

Citing Articles

Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis.

Heydemann L, Ciurkiewicz M, Stork T, Zdora I, Hulskotter K, Gregor K Nat Commun. 2025; 16(1):2080.

PMID: 40021627 PMC: 11871369. DOI: 10.1038/s41467-025-57267-x.


High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.

Watkins T, Green A, Amat J, Cheemarla N, Hansel K, Lozano R J Exp Med. 2024; 221(9).

PMID: 38949638 PMC: 11215523. DOI: 10.1084/jem.20230911.


Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.

Clark J, Penrice-Randal R, Sharma P, Dong X, Pennington S, Marriott A Viruses. 2024; 16(6).

PMID: 38932155 PMC: 11209060. DOI: 10.3390/v16060863.

References
1.
Mudd P, Crawford J, Turner J, Souquette A, Reynolds D, Bender D . Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020; 6(50). PMC: 7725462. DOI: 10.1126/sciadv.abe3024. View

2.
Wissinger E, Goulding J, Hussell T . Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin Immunol. 2009; 21(3):147-55. DOI: 10.1016/j.smim.2009.01.005. View

3.
Kulkarni R, Rasheed M, Bhaumik S, Ranjan P, Cao W, Davis C . Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. J Virol. 2014; 88(24):13990-4001. PMC: 4249139. DOI: 10.1128/JVI.02273-14. View

4.
Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M . Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021; 50(4):1124-1133. PMC: 8135706. DOI: 10.1093/ije/dyab081. View

5.
Kinoshita T, Watanabe K, Sakurai Y, Nishi K, Yoshikawa R, Yasuda J . Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep. 2021; 11(1):21259. PMC: 8553868. DOI: 10.1038/s41598-021-00809-2. View